Results 111 to 120 of about 78,793 (257)

The evolutionary landscape and serotypic dynamics of avian infectious bronchitis virus from spike protein

open access: yesiMetaOmics, Volume 3, Issue 1, March 2026.
This study integrates two decades of surveillance with genomic and structural analyses to decipher how spike protein glycosylation haplotypes drive avian coronavirus evolution. We uncover how specific glycosylation patterns associate with receptor‐binding affinity, shape global transmission dynamics, and correlate with clinical outcomes.
Hao Zhang   +21 more
wiley   +1 more source

Modificările morfopatologice ale rinichilor în bronşita infecţioasă aviară

open access: yesAgricultural Science, 2010
The article presents the results of morpho-pathological modifications and lesions in kidneys of chickens infected with avian infectious bronchitis virus at the age of three months, in a private poultry farm from Cantemir district. The morpho-pathological
STARCIUC N. , OSADCI Natalia
doaj  

Newcastle and Infectious Bronchitis Vaccine Reactions in Commercial Broilers

open access: yesEDIS, 2003
There is considerable confusion in the commercial broiler industry relating to vaccination with Newcastle (ND) and infectious bronchitis (IB) vaccines.
Gary D. Butcher   +2 more
doaj   +1 more source

The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis. [PDF]

open access: yes, 2010
The syndrome of chronic obstructive pulmonary disease (COPD) consists of chronic bronchitis (CB), bronchiectasis, emphysema, and reversible airway disease that combine uniquely in an individual patient.
Albertson, Timothy E   +2 more
core  

Akkermansia muciniphila enhances chicken resistance to infectious bronchitis virus by boosting GABA synthesis and suppressing the NF‐κB inflammatory pathway

open access: yesiMetaOmics, Volume 3, Issue 1, March 2026.
Infectious bronchitis virus (IBV) represents a major threat to poultry production, with current control strategies offering limited protection. In this study, we demonstrate gut microbiome is a critical determinant of IBV resistance using fecal microbiota transplantation.
Ouyang Peng   +22 more
wiley   +1 more source

Differential Induction and Signaling of Type I and III Interferons During Infection of Human Nasal Epithelial Cells With the Four Human Parainfluenza Virus Types

open access: yesJournal of Medical Virology, Volume 98, Issue 3, March 2026.
ABSTRACT Human parainfluenza viruses (HPIVs) commonly cause croup and lower respiratory tract infections in young children. Despite typically self‐limiting with mild symptoms, the innate immune responses to HPIVs remain poorly understood, especially across all four types in human nasal epithelial cells (hNECs), the primary infection site.
Hsiao Hui Ong   +6 more
wiley   +1 more source

Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

open access: yesJEADV Clinical Practice, Volume 5, Issue 1, Page 101-116, March 2026.
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson   +12 more
wiley   +1 more source

Avian Infectious Bronchitis Virus

open access: yes, 1983
This chapter provides an overview of the classification, description, hosts, key developments, diagnostic techniques, and diagnostic reagents for avian infectious bronchitis virus. Avian infectious bronchitis virus belongs to the family Coronaviridae; genus Coronavirus; and species Avian infectious bronchitis virus.
openaire   +1 more source

Understanding the Twentieth Century Decline in Chronic Conditions Among Older Men [PDF]

open access: yes
I use a sample of Union Army veterans to trace the impact of a high infant mortality rate in area of enlistment, such infectious disease as acute respiratory infections, measles, typhoid fever, tuberculosis, rheumatic fever, diarrhea, and malaria while ...
Dora L. Costa
core  

Weekly Subcutaneous VK2735, a GIP/GLP‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study

open access: yesObesity, Volume 34, Issue 3, Page 537-549, March 2026.
Four doses of VK2735 and a placebo group were included in the VENTURE study. Adults who were overweight or had obesity had significant weight loss when taking any dose of VK2735 for 13 weeks. More people lost at least 10% of their body weight as the dose increased.
Harold E. Bays   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy